230 related articles for article (PubMed ID: 33420566)
41. Prophylactic thoracic duct ligation is associated with poor prognosis and regional lymph node relapse in esophageal squamous cell carcinoma.
Chen JY; Liu QW; Zhang SS; Li JB; Yang H; Wen J; Fu JH
J Surg Oncol; 2020 Aug; 122(2):336-343. PubMed ID: 32410255
[TBL] [Abstract][Full Text] [Related]
42. [Influence of number of removed lymph nodes on the TNM staging and survival in advanced esophageal carcinoma].
Chen LQ; Hu CY; Zhang HL; He M; Meng XL; Ping YM
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):604-8. PubMed ID: 18210881
[TBL] [Abstract][Full Text] [Related]
43. Clinicopathologic Features of Submucosal Esophageal Squamous Cell Carcinoma.
Emi M; Hihara J; Hamai Y; Furukawa T; Ibuki Y; Okada M
Ann Thorac Surg; 2017 Dec; 104(6):1858-1864. PubMed ID: 29033014
[TBL] [Abstract][Full Text] [Related]
44. [Analysis of lymph node metastasis in the thoracic esophageal squamous cell carcinoma].
Zhu ZJ; Zhao YF; Hu Y; Chen LQ; Liu LX; Wu Z; Kou YL; Wang Y
Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):138-40. PubMed ID: 18646699
[TBL] [Abstract][Full Text] [Related]
45. Nodal skip metastasis is associated with a relatively poor prognosis in thoracic esophageal squamous cell carcinoma.
Liu J; Liu Q; Wang Y; Xia Z; Zhao G
Eur J Surg Oncol; 2016 Aug; 42(8):1202-5. PubMed ID: 27266407
[TBL] [Abstract][Full Text] [Related]
46. Clinical Impact of Metastatic Lymph Node Size on Therapeutic Effect and Prognosis in Patients with Esophageal Squamous Cell Carcinoma Who Underwent Preoperative Chemotherapy Followed by Esophagectomy.
Sugimura K; Miyata H; Kanemura T; Takeoka T; Sugase T; Yamamoto M; Shinnno N; Hara H; Omori T; Motoori M; Ohue M; Yano M
Ann Surg Oncol; 2023 Jul; 30(7):4193-4202. PubMed ID: 37010661
[TBL] [Abstract][Full Text] [Related]
47. [Lymphatic metastasis intensity of and lymphadenectomy for thoracic esophageal squamous cell carcinoma].
Lu ZM; Zhang H; Wang MH; Cui DH; Yang YQ; Huang HZ
Ai Zheng; 2006 May; 25(5):604-8. PubMed ID: 16687083
[TBL] [Abstract][Full Text] [Related]
48. Prophylactic supraclavicular lymph node dissection for esophageal squamous cell carcinoma: a systematic review and meta-analysis.
Tsunoda S; Hoshino N; Yoshida S; Obama K
Surg Today; 2023 Jun; 53(6):647-654. PubMed ID: 35798906
[TBL] [Abstract][Full Text] [Related]
49. Pattern of lymph node metastases in patients with squamous cell carcinoma of the thoracic esophagus who underwent three-field lymphadenectomy.
Li H; Zhang Y; Cai H; Xiang J
Eur Surg Res; 2007; 39(1):1-6. PubMed ID: 17106199
[TBL] [Abstract][Full Text] [Related]
50. Letter to the Editor: Comparison of Outcomes Between Additional Esophagectomy After Noncurative Endoscopic Resection and Upfront Esophagectomy for T1N0 Esophageal Squamous Cell Carcinoma.
Liu Z; Li Z
Ann Surg Oncol; 2021 Dec; 28(Suppl 3):837-838. PubMed ID: 33956274
[No Abstract] [Full Text] [Related]
51. [Clinical value of para-recurrent laryngeal nerve lymphadenectomy for middle thoracic esophageal squamous cell carcinoma].
Wang Z; Liu S
Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Sep; 18(9):867-70. PubMed ID: 26404679
[TBL] [Abstract][Full Text] [Related]
52. Author's Reply: Comparison of Outcomes Between Additional Esophagectomy After Noncurative Endoscopic Resection and Upfront Esophagectomy for T1N0 Esophageal Squamous Cell Carcinoma.
Maruyama S; Okamura A; Watanabe M
Ann Surg Oncol; 2021 Dec; 28(Suppl 3):839-840. PubMed ID: 33970373
[No Abstract] [Full Text] [Related]
53. Impact of Lymph Node Ratio on Survival Outcome in Esophageal Squamous Cell Carcinoma After Minimally Invasive Esophagectomy.
Kitamura Y; Oshikiri T; Takiguchi G; Urakawa N; Hasegawa H; Yamamoto M; Kanaji S; Yamashita K; Matsuda T; Fujino Y; Tominaga M; Nakamura T; Suzuki S; Kakeji Y
Ann Surg Oncol; 2021 Aug; 28(8):4519-4528. PubMed ID: 33393049
[TBL] [Abstract][Full Text] [Related]
54. Multimodal treatment for lymph node recurrence of esophageal carcinoma after curative resection.
Nakamura T; Ota M; Narumiya K; Sato T; Ohki T; Yamamoto M; Mitsuhashi N
Ann Surg Oncol; 2008 Sep; 15(9):2451-7. PubMed ID: 18592318
[TBL] [Abstract][Full Text] [Related]
55. A strategy for supraclavicular lymph node dissection using recurrent laryngeal nerve lymph node status in thoracic esophageal squamous cell carcinoma.
Taniyama Y; Nakamura T; Mitamura A; Teshima J; Katsura K; Abe S; Nakano T; Kamei T; Miyata G; Ouchi N
Ann Thorac Surg; 2013 Jun; 95(6):1930-7. PubMed ID: 23642437
[TBL] [Abstract][Full Text] [Related]
56. Salvage lymphadenectomy versus salvage radiotherapy/chemoradiotherapy for recurrence in cervical lymph node after curative resection of esophageal squamous cell carcinoma.
Ma X; Zhao K; Guo W; Yang S; Zhu X; Xiang J; Zhang Y; Li H
Ann Surg Oncol; 2015 Feb; 22(2):624-9. PubMed ID: 25155397
[TBL] [Abstract][Full Text] [Related]
57. [Associated factors of postoperative relapse and metastasis in pT1bN0M0-pT4aN0M0 thoracic esophageal squamous cell carcinoma].
Pan W; Xiang Y; Gu Z; Ji C; Mao T; Fang W
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1045-1049. PubMed ID: 28900998
[TBL] [Abstract][Full Text] [Related]
58. [Efficacy comparison of Sweet versus Ivor-Lewis esophagectomy in the treatment of middle-lower esophageal squamous cell carcinoma].
Yang X; Zhan C; Sun F; Chen L; Shi M; Jiang W; Wang Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Sep; 19(9):979-984. PubMed ID: 27680063
[TBL] [Abstract][Full Text] [Related]
59. Recurrent esophageal carcinoma after esophagectomy with three-field lymph node dissection.
Kato H; Tachimori Y; Watanabe H; Igaki H; Nakanishi Y; Ochiai A
J Surg Oncol; 1996 Apr; 61(4):267-72. PubMed ID: 8627996
[TBL] [Abstract][Full Text] [Related]
60. Solitary Lymph Node Recurrence of Esophageal Squamous Cell Carcinoma: Surgical Failure or Systemic Disease?
Makino T; Yamasaki M; Miyata H; Tanaka K; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
Ann Surg Oncol; 2016 Jun; 23(6):2087-93. PubMed ID: 26762271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
